ProBiotix Health plc
Company Profile
Company website
Sector
Pharmaceuticals and Biotechnology (Biotechnology)
Description
Description: ProBiotix Health (AQSE: PBX) is a spin-out of OptiBiotix Health Plc. The Company was established in 2018, with the purpose to provide consumers and industry world-wide with uncompromised supply and service of safe and scientifically validated probiotic-based microbiome product solutions for improvement of human health.
ProBiotix Health hold a unique position within fast growing cardiovascular health segment and has become a global leader for development and marketing of finished dietary supplement and OTC probiotic based microbiome solution aiming at lowering of cholesterol and blood pressure using its principal strain, LPLDL®.
Not all Walbrook clients have a handy 2 page summary available. Click on "Register your interest" and we'll let the Company know that you think this would be useful
Latest Company Summary
Investor Access
08
Aug
Event information
Management will hold the company’s AGM on Thursday 8 August 2024.
Venue
Offices of Peterhouse Capital Limited, 3rd Floor, 80 Cheapside, London, EC2V 6EE
Time
Thursday 8 August 2024 at 13:30
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results | 28 June |
| Interim Results* | September |
| AGM | 8 August |
* Months based on previous announcements of this kind
